Last reviewed · How we verify
NCT05603481: CGM
CGM in Patients With ED's
trial testing Continuous Glucose Monitor in Anorexia Nervosa Restricting Type in 50 participants. Completed in 2 July 2024.
1 July 2024
Quick facts
| Lead sponsor | Denver Health and Hospital Authority |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 9 May 2023 |
| Primary completion | 1 July 2024 |
| Estimated completion | 2 July 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Continuous Glucose Monitor
Conditions studied
- Anorexia Nervosa Restricting Type — all drugs for Anorexia Nervosa Restricting Type →
- Anorexia Nervosa, Binge Eating/Purging Type — all drugs for Anorexia Nervosa, Binge Eating/Purging Type →
- ARFID — all drugs for ARFID →
- Avoidant Restrictive Food Intake Disorder — all drugs for Avoidant Restrictive Food Intake Disorder →
Sponsor
Denver Health and Hospital Authority
Who can join
Adults 18 to 65, any sex, with Anorexia Nervosa Restricting Type or Anorexia Nervosa, Binge Eating/Purging Type. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To determine the accuracy of continuous glucose monitoring (CGM) with point of care (POC) fingerstick glucose monitoring and venous blood glucose in patients with eating disorders, specifically anorexia nervosa, restricting subtype (AN-R); avoidant/restrictive food intake disorder (ARFID); and anorexia nervosa, binge/purge subtype (AN-BP).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05603481
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Continuous Glucose Monitor
Trials testing the same drug.
- NCT07221812 — Continuous Glucose Monitors (CGMs) and Readmission Rates · NA · not yet recruiting
- NCT05548205 — Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge · NA · recruiting
- NCT06643611 — Addressing Disparities in Diabetes Care · NA · completed
- NCT06501612 — Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7 · NA · completed
- NCT05317585 — Continuous Glucose Monitor Use in Pregnancy · NA · recruiting
Other recruiting trials for Anorexia Nervosa Restricting Type
Currently open trials in the same condition.
- NCT06050421 — Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa · NA · recruiting
- NCT05885724 — Novel Targetable BIOmarkers in ANorexia NervosA · recruiting
Other Denver Health and Hospital Authority trials
Trials by the same sponsor.
- NCT07435662 — Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver · NA · recruiting
- NCT06496035 — Blood Flow Restriction Training in Patients With Lower Extremity Fractures · NA · recruiting
- NCT06274359 — Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities · NA · terminated
- NCT07223918 — Personalized Decision-Aid to Guide Tracheostomy and Prolonged Mechanical Ventilation Decision-Making · completed
- NCT06033365 — Beginning Early and Assertive Treatment for Methamphetamine Use Disorder · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05603481 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Denver Health and Hospital Authority
- Last refreshed: 5 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05603481.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing